ProMIS Neurosciences, Inc.
PMN
$7.39
-$0.05-0.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 231.87% | 196.52% | 115.16% | 34.95% | -29.10% |
| Gross Profit | -231.87% | -196.52% | -115.16% | -34.95% | 29.10% |
| SG&A Expenses | -42.20% | -38.59% | -51.60% | -57.84% | -10.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.99% | 92.31% | 31.94% | -6.56% | -22.27% |
| Operating Income | -116.99% | -92.31% | -31.94% | 6.56% | 22.27% |
| Income Before Tax | -5,097.59% | 30.92% | 92.14% | 121.03% | 96.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5,097.59% | 30.92% | 92.14% | 121.03% | 96.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5,097.59% | 30.92% | 92.14% | 121.03% | 96.67% |
| EBIT | -116.99% | -92.31% | -31.94% | 6.56% | 22.27% |
| EBITDA | 82.97% | 45.69% | 25.56% | 6.57% | 22.43% |
| EPS Basic | -286.81% | 71.27% | 95.02% | 98.64% | 89.87% |
| Normalized Basic EPS | -234.63% | 85.77% | 107.12% | 106.86% | 89.87% |
| EPS Diluted | -288.32% | 71.27% | 95.02% | 98.64% | 89.87% |
| Normalized Diluted EPS | -233.80% | 85.70% | 107.06% | 106.83% | 89.84% |
| Average Basic Shares Outstanding | 72.48% | 88.80% | 98.88% | 112.05% | 134.27% |
| Average Diluted Shares Outstanding | 72.39% | 88.87% | 98.95% | 112.14% | 134.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |